Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Reduction metabolism, principles

The principles of oxidation-reduction energetics described above apply to the many metabolic reactions that involve electron transfers. For example, in many organisms, the oxidation of glucose supplies energy for the production of ATP. The complete oxidation of glucose ... [Pg.512]

Figure 7.9 The metabolism of halothane and its proposed involvement in liver toxicity. Pathway I (oxidative) and pathway 2 (reductive) are both catalyzed by cytochrome P450. Source J. A. Timbrell (1991), Principles of Biochemical Toxicology, 2nd ed. London Taylor Francis. Figure 7.9 The metabolism of halothane and its proposed involvement in liver toxicity. Pathway I (oxidative) and pathway 2 (reductive) are both catalyzed by cytochrome P450. Source J. A. Timbrell (1991), Principles of Biochemical Toxicology, 2nd ed. London Taylor Francis.
NAD(P)H concentration in biomass and its ratio to NAD(P) gives a measure for the culture reduction status [35]. NAD(P)H can, in principle, be detected directly in vivo by in situ fluorescence measurement (see the chapter by Sonnleitner in this volume - the section on culture fluorescence). This measure serves as a biomass concentration sensor if the specific NAD(P)H concentration stays constant. If not, the ratio of culture fluorescence and biomass concentration, the specific fluorescence, can be a measure for the culture reduction state, or indicate other more complex events like metabolic pathway shifts [35] or even the formation of a variant in a culture [36] (see also Figs. 2 and 3). [Pg.193]

Chapter 1 examined three risperidone studies that confirm the braindisabling principles of psychiatric treatment by demonstrating that the drug causes a metabolic suppression in the frontal and temporal lobes (deactivation) that occurs in both normal persons and patients diagnosed with schizophrenia, and that this disabling effect correlates with a reduction in the expression of symptoms, such as hallucinations and delusions, that require a fully functioning brain. As previously noted, if measured, the effect would also correlate with an overall reduction in spontaneous mental activity and verbal expressions, which are common clinical phenomena in patients who experience psychomotor retardation in response to neuroleptics. [Pg.28]

The indication for administering BCAA in patients with hepatic encephalopathy to compensate amino-acid imbalance was proposed by J.E. Fischer et al. in 1974, and implemented parenterally. However, oral application of BCAA for an adequate treatment period also has beneficial effects on cirrhosis and HE (7.) improvement in protein tolerance and the nutritional condition, (2.) improvement in cerebral functions (II8, 122), probably due to an amelioration of liver function, (2.) stimulation of ammonia detoxification with a positive nitrogen balance (118), (4.) reduction in or normalization of AAA levels, and (5.) promotion of glutamine synthesis with a favourable effect on the cells of the immune system and on renal function. By means of BCAA, it was possible to prolong the survival time and delay the occurrence of liver failure in rats with CC -induced cirrhosis. (123, 126) However, there are diverging results, which need further clarification. In principle, the use of BCAA is considered to be a necessary form of supplementary treatment for catabolic metabolism in cirrhosis (124,125, 127, 128, 130-132), in (also latent) HE and after curative resection of hepatocellular carcinoma. (I2l) (s. p. 280)... [Pg.861]

Furthermore, pharmacokinetic administration, distribution, metabolism and excretion (ADME) factors affect drug bioavailability, efficacy and safety, and, thus, are a vital consideration in the selection process of oral drug candidates in development pipelines. Since solubility, permeability, and the fraction of dose absorbed are fundamental BCS parameters that affect ADME, these BCS parameters should prove useful in drug discovery and development. In particular, the classification can used to make the development process more efficient.For example, in the case of a drug placed in BCS Class II where dissolution is the rate-limiting step to absorption, formulation principles such as polymorph selection, salt selection, complex formation, and particle size reduction (i.e., nanoparticles) could be applied earlier in development to improve bioavailability. [Pg.926]

The metabolic N2-fixation occurs practically exclusively by microorganisms160,161 living under different conditions (aerorobic, anaerobic, autonom or symbiotic) and it is not restricted to photoautotrophs. Though the diversity of the metabolic states, the N2-fixation seems to be performed according to a unique functional principle. N2-fixation occurs practically exclusively by reduction to the state of ammonium. [Pg.70]

Chapters 15 through 24 explore intermediary metabolism. Chapter 15 opens the topic with chemical principles that provide some unifying themes. Thermodynamic concepts learned earlier in general chemistry and in Chapter 1 are applied specifically to biochemical topics such as coupled reactions. In addition, this chapter explic-idy makes the connection between metabolism and electron transfer (oxidation-reduction) reactions. [Pg.835]


See other pages where Reduction metabolism, principles is mentioned: [Pg.408]    [Pg.49]    [Pg.51]    [Pg.21]    [Pg.86]    [Pg.120]    [Pg.253]    [Pg.3]    [Pg.213]    [Pg.123]    [Pg.1070]    [Pg.319]    [Pg.243]    [Pg.537]    [Pg.101]    [Pg.390]    [Pg.2]    [Pg.379]    [Pg.179]    [Pg.108]    [Pg.797]    [Pg.143]    [Pg.5071]    [Pg.228]    [Pg.849]    [Pg.1906]    [Pg.485]    [Pg.230]    [Pg.18]    [Pg.4]    [Pg.684]    [Pg.80]    [Pg.406]    [Pg.207]    [Pg.439]    [Pg.615]    [Pg.439]    [Pg.334]    [Pg.33]    [Pg.71]   
See also in sourсe #XX -- [ Pg.151 , Pg.152 ]




SEARCH



Metabolism reductive

Reduction principle

© 2024 chempedia.info